Počet záznamů: 1  

Multifunctional graphene quantum dots: A therapeutic strategy for neurodegenerative diseases by regulating calcium influx, crossing the blood-brain barrier and inhibiting Aβ-protein aggregation

  1. 1.
    SYSNO ASEP0584540
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevMultifunctional graphene quantum dots: A therapeutic strategy for neurodegenerative diseases by regulating calcium influx, crossing the blood-brain barrier and inhibiting Aβ-protein aggregation
    Tvůrce(i) Gómez, I. J. (CZ)
    Křížková, P. (CZ)
    Dolečková, A. (CZ)
    Cardo, L. (ES)
    Wetzl, C. (ES)
    Pizúrová, Naděžda (UFM-A) RID, ORCID
    Prato, M. (ES)
    Medalová, J. (CZ)
    Zajíčková, L. (CZ)
    Celkový počet autorů9
    Číslo článku102072
    Zdroj.dok.Applied Materials Today. - : Elsevier - ISSN 2352-9407
    Roč. 36, FEB (2024)
    Poč.str.9 s.
    Jazyk dok.eng - angličtina
    Země vyd.NL - Nizozemsko
    Klíč. slovacarbon nano-onions ; abc transporters ; nanotubes ; memantine ; mechanism ; model ; size ; Carbon dots ; Memantine ; Protein aggregation ; Blood-brain barrier ; Bioimaging
    Výzkumná infrastrukturaCzechNanoLab - 90110 - Vysoké učení technické v Brně
    Způsob publikováníOpen access
    Institucionální podporaUFM-A - RVO:68081723
    UT WOS001171819100001
    EID SCOPUS85183459574
    DOI10.1016/j.apmt.2024.102072
    AnotaceMultifunctional nanoparticles could be the hallmark for the treatment of neurodegenerative diseases. Dissociation of protein aggregates causing neuronal damage and transfer of specific drugs which can downregulate neuronal excitotoxicity by inhibiting glutamatergic N-Methyl-D-Aspartate-receptors (NMDA) and then reducing calcium influx are among the main factors to consider for proper therapy. Here, we present a multiplatform based on nitrogen-doped graphene quantum dots (NGQDs) with such functionalities. The NGQDs were functionalized with Memantine, the clinically used drug, via covalent and non-covalent coupling, and we confirmed that the pharmaceutical activity was not altered. Apart from that, using xCELLigence technology and flow cytometric analysis of ABC transporter function, we uncovered that the ABC transporters of the blood-brain barrier (BBB) do not affect the ability of NGQD to cross BBB. Surprisingly, this study found that NGQDs have an inhibitory effect on NMDA receptors, thus supporting the action of Memantine. Moreover, NGQDs and their derivatives demonstrated the potential to dissociate beta-amyloid aggregates while possessing features suitable for bioimaging in various cell lines.
    PracovištěÚstav fyziky materiálu
    KontaktYvonna Šrámková, sramkova@ipm.cz, Tel.: 532 290 485
    Rok sběru2025
    Elektronická adresahttps://www.sciencedirect.com/science/article/pii/S2352940724000180?via%3Dihub
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.